Abstract
Tubercidin represents one of the most widely recognized nucleosides isolated from natural sources. The major structural difference between adenosine and tubercidin is that one of the nitrogen atom is replaced by a C-H group in the heterocyclic base. Tubercidin was first introduced into the clinic over 40 years ago. Since then, there has been a steady interest and this review discusses the various approaches related to the synthesis of tubercidin and its derivatives. The key aspects related to isolation, structure-activity relationships and biological activity are also discussed.
Keywords: Tubercidin, natural product, nucleosides, antibiotic, synthesis.
Graphical Abstract
Current Organic Chemistry
Title:Tubercidin and Related Analogues: An Inspiration for 50 years in Drug Discovery
Volume: 20 Issue: 8
Author(s): Varughese A. Mulamoottil
Affiliation:
Keywords: Tubercidin, natural product, nucleosides, antibiotic, synthesis.
Abstract: Tubercidin represents one of the most widely recognized nucleosides isolated from natural sources. The major structural difference between adenosine and tubercidin is that one of the nitrogen atom is replaced by a C-H group in the heterocyclic base. Tubercidin was first introduced into the clinic over 40 years ago. Since then, there has been a steady interest and this review discusses the various approaches related to the synthesis of tubercidin and its derivatives. The key aspects related to isolation, structure-activity relationships and biological activity are also discussed.
Export Options
About this article
Cite this article as:
A. Mulamoottil Varughese, Tubercidin and Related Analogues: An Inspiration for 50 years in Drug Discovery, Current Organic Chemistry 2016; 20 (8) . https://dx.doi.org/10.2174/1385272819666150803231652
DOI https://dx.doi.org/10.2174/1385272819666150803231652 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Genetic Basis of Graves Disease
Current Genomics Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Current Pharmaceutical Design Polyamine Modulation of NMDARs as a Mechanism to Reduce Effects of Alcohol Dependence
Recent Patents on CNS Drug Discovery (Discontinued) Recent Advances in Computational Studies on Influenza A Virus M2 Proton Channel
Mini-Reviews in Medicinal Chemistry Migraine in Systemic Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Chemokines and Chemokine Receptors Blockers as New Drugs for the Treatment of Chronic Obstructive Pulmonary Disease
Current Medicinal Chemistry Relevance of Anxiety and Depression in Chronic Obstructive Pulmonary Disease (COPD)
Current Respiratory Medicine Reviews Glycation With Fructose: The Bitter Side of Nature’s Own Sweetener
Current Diabetes Reviews Advances in Metabonomics on Infectious Diseases
Current Metabolomics Energy Metabolism, Adult Neurogenesis and their Possible Roles in Alzheimer’s Disease: A Brief Overview
Current Topics in Medicinal Chemistry β-Amyloid Fibrillation and/or Hyperhomocysteinemia Modify Striatal Patterns of Hyaluronic Acid and Dermatan Sulfate: Possible Role in the Pathogenesis of Alzheimers Disease
Current Alzheimer Research Risk Factors for Suicide – An Alternative View
CNS & Neurological Disorders - Drug Targets Advances in Whole Genome Sequencing Technology
Current Pharmaceutical Biotechnology An Arylidene-Thiazolidinedione Derivative, GPU-4, without PPARγ Activation, Reduces Retinal Neovascularization
Current Neurovascular Research Predictive QSAR Modeling Workflow, Model Applicability Domains, and Virtual Screening
Current Pharmaceutical Design Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets Positive Association Between Plasma Levels of Advanced Glycation and Precursor of Lipoxidation end Products with Gastrointestinal Problems in Children with Autism
Current Pediatric Reviews Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients
Current Alzheimer Research Editorial: (Thematic Issue: Autoimmune diseases: What have we learned from mice?)
Current Pharmaceutical Design Design, Synthesis, and Screening of Hybrid Benzothiazolyl-Oxadiazoles as Anticonvulsant Agents
Letters in Drug Design & Discovery